Literature DB >> 12843631

Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs.

Arjun Ram1, Moumita Das, Balaram Ghosh.   

Abstract

Anti-asthmatic property of curcumin (diferuloylmethane), a natural product from the rhizomes of Curcuma longa, has been tested in a guinea pig model of airway hyperresponsiveness. We sensitized guinea pigs with ovalbumin (OVA) to develop certain characteristic features of asthma: allergen induced airway constriction and airway hyperreactivity to histamine. Guinea pigs were treated with curcumin during sensitization (to examine its preventive effect) or after developing impaired airways features (to examine its therapeutic effect). Status of airway constriction and airway hyperreactivity were determined by measuring specific airway conductance (SGaw) using a non-invasive technique, constant-volume body plethysmography. Curcumin (20 mg/kg body weight) treatment significantly inhibits OVA-induced airway constriction (p<0.0399) and airway hyperreactivity (p<0.0043). The results demonstrate that curcumin is effective in improving the impaired airways features in the OVA-sensitized guinea pigs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843631     DOI: 10.1248/bpb.26.1021

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  20 in total

1.  Combination Therapy with Curcumin Alone Plus Piperine Ameliorates Ovalbumin-Induced Chronic Asthma in Mice.

Authors:  Preeti S Chauhan; Anju Jaiswal; Rashmi Singh
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 2.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

Review 3.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

Review 4.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

5.  Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment.

Authors:  Constanze Buhrmann; Ali Mobasheri; Ulrike Matis; Mehdi Shakibaei
Journal:  Arthritis Res Ther       Date:  2010-07-01       Impact factor: 5.156

Review 6.  The antioxidant response element and oxidative stress modifiers in airway diseases.

Authors:  Sekhar P Reddy
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

7.  Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma.

Authors:  Afroz Abidi; Surabhi Gupta; Manu Agarwal; H L Bhalla; Mahip Saluja
Journal:  J Clin Diagn Res       Date:  2014-08-20

Review 8.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

9.  Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles.

Authors:  Wenrui Wang; Rongrong Zhu; Qian Xie; Ang Li; Yu Xiao; Kun Li; Hui Liu; Daxiang Cui; Yihan Chen; Shilong Wang
Journal:  Int J Nanomedicine       Date:  2012-07-17

10.  Oral curcumin supplementation in patients with atopic asthma.

Authors:  Dennis H Kim; Joshua F Phillips; Richard F Lockey
Journal:  Allergy Rhinol (Providence)       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.